Navigation Links
ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
Date:10/29/2008

br /> For the year 2008, ViroPharma expects the following

-- Net Vancocin sales are expected to be $235 to $245 million;

-- Research and development (R&D) and selling, general and administrative

(SG&A) expenses, excluding the impact of SFAS 123R, are expected to be

$115 to $125 million.

-- The SFAS 123R impact to the above expenses will be approximately 9

million. Including the impact of SFAS 123R, the research and

development (R&D) and sales, general and administrative (SG&A) expenses

are expected to be between $124 and $134 million.

Non-GAAP Disclosures

This press release includes non-GAAP financial information as the Company's projected research and development and marketing, general and administrative expenses has been presented excluding the effect of stock option expense resulting from the application of SFAS 123R. The Company believes that presenting its research and development (R&D) expense and sales, general and administrative (SG&A) expense in this release both with and without the impact of share-based compensation will allow investors to better understand the Company's financial results and how such results compare with the Company's prior results and current guidance.

Conference Call and Webcast

ViroPharma is hosting a live teleconference and webcast with senior management to discuss the financial announcement, guidance, and other business results on October 29, 2008 at 9:00 a.m. Eastern Time. To participate in the conference call, please dial 877-366-0713 (domestic) and 302-607-2000 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

Alternatively, the live webcast of the conference call can be accessed via ViroPharma's website at http://www.viropharma.com. Windows Media or Real Player will be needed to access the webcast. An a
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
2. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
4. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
5. ViroPharma Provides Update on Vancocin(R)
6. ViroPharma Augments Senior Management
7. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
8. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
9. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. ViroPharma to Present at the Maxim Group First Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Woburn, MA (PRWEB) June 19, 2013 ... brand of advanced carpet cleaning machines, including reliable ... highly ranked grout cleaning machine systems , ... the XTreme Power® XPH-5900I for auto detailing professionals. ... the 5000 series of Daimer® models, is ideal ...
(Date:6/19/2013)... UK (PRWEB) June 19, 2013 Tools4ever, ... is sponsoring today's event, at which it will be ... as well as giving further insight into its leading-edge ... for IT & business professionals specialising in IDM infrastructure ... range of markets including the public sector, banking, finance ...
(Date:6/19/2013)... Men often deal with gastrointestinal health issues ... to what they are consuming on a daily basis. With ... and supplier of Siberian pine nut oil, PineNutOil.org , ... healing elements within pine nut oil. , Stomach ... ulcers within the gastrointestinal tract that are usually acidic and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Indosoft ... Center ACD for Asterisk, announced today the ... 5.7. This enhancement offers improved options for extracting, ... dashboards for effective contact center management. , Large ... real-time captured as it happens from the call ...
(Date:6/19/2013)... 19, 2013 On 31 May 2013, ... about involuntarily detaining patients, a proposal put forward from ... and mental health service provider , The Australian Addiction ... the suggestion. The centre’s Director and natural healing ... suffering from mental health issues have no voice. I ...
Breaking Medicine News(10 mins):Health News:Daimer Ships Carpet Cleaners for Car Detailing Steam Cleaner Tasks 2Health News:Daimer Ships Carpet Cleaners for Car Detailing Steam Cleaner Tasks 3Health News:Pine Nut Oil is a Proven Remedy for Stomach Ulcers 2Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2Health News:Involuntary Detention Proposal Dehumanizing, Says Holistic Mental Health Service Provider The Australian Addiction And Trauma Treatment Centre 2Health News:Involuntary Detention Proposal Dehumanizing, Says Holistic Mental Health Service Provider The Australian Addiction And Trauma Treatment Centre 3
... Do,Lunch, Inc. is bringing women with alopecia areata ... different from a traditional,support group, the non-profit,s dining ... public awareness. Founder and president,Thea Chassin, bald for ... the,country. According to Chassin, "Our congenial approach is ...
... Brochure as Key Patient Resource on Restorative Options, ... Dental,Association (PDA) is recommending that PDA member dentists ... Association (ADA) when discussing,restorative options with patients., ... give,patients the latest information on oral health issues," ...
... A new study shows that exposure to a chemical ... be harmful to the nose and airways of mice. ... (NIEHS), part of the National Institutes of Health, conducted ... obliterative bronchiolitis (OB) in humans. OB is a debilitating ...
... Surgery is the only curative treatment in patients ... concept a reliable diagnostic procedure is of great ... growth along the bile duct, imaging techniques including ... of limited sensitivity for the detection of bile ...
... Society invites medical and science reporters to attend a special ... learn whats new in the fight against cancer and hear ... Society. This informative media briefing will offer the latest trends ... research, prevention, early detection, patient services, and more. , The ...
... consumption increases the risk of ESCC. There are synergetic ... The risk of ESCC in moderate-to-heavy drinkers, ALDH2 (1/2) ... with the CYP2E1 (c1/c1) genotype; leads to synergetic interactions, ... + 2/2); ALDH2 (1/1) + CYP2E1 (c1/c2 + c2/c2). ...
Cached Medicine News:Health News:In Northern California Bald Women Get Their Heads Together 2Health News:Pennsylvania Dental Association Urges Members to Use New ADA Educational Material 2Health News:Rodent study finds artificial butter chemical harmful to lungs 2Health News:American Cancer Society science reporters briefing to feature latest developments in cancer 2Health News:American Cancer Society science reporters briefing to feature latest developments in cancer 3Health News:Alcohol consumption and polymorphisms of cytochromes P4502E1 are high risks for ESCC 2
(Date:6/19/2013)... June 19, 2013  It may seem like an odd ... breast cancer. But these were two of the most talked ... Annual Meeting & Expo that just convened in ... this focus by some of the top internal medicine experts ... with new research that can not only save lives, but ...
(Date:6/18/2013)... 19, 2013 , Safinamide ... (PD) patients as add-on to levodopa ... motor symptoms in fluctuating PD patients as add-on ... Pharmaceuticals S.p.A. ("Newron"), a research and development company ... its partner Zambon S.p.A., a pharmaceutical company strongly ...
(Date:6/18/2013)... 18, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... announced today that VPII Escrow Corp., a newly formed ... its offer of approximately $3.2 billion aggregate principal amount ... be due in 2021 and in 2023, with final ... to use the net proceeds from the offering, together ...
Breaking Medicine Technology:"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
... 2011 Reportlinker.com announces that a new market ... Pharmaceutical Distributors - Europe ... This register contains information about 2063 ... includes the following information about the distributors: ...
... Reportlinker.com announces that a new market research ... Pharmaceutical Manufacturers - Europe ... This register contains information about 3251 manufacturers ... the following details of the manufacturers: ...
Cached Medicine Technology:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: